UBS Group AG - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$266,000
+11.8%
84,455
+3.4%
0.00%
Q2 2020$238,000
-37.0%
81,695
-39.0%
0.00%
Q1 2020$378,000
-25.9%
133,945
-14.8%
0.00%
Q4 2019$510,000
-82.4%
157,155
-88.3%
0.00%
-100.0%
Q3 2019$2,903,000
-2.6%
1,343,993
+41.6%
0.00%0.0%
Q2 2019$2,982,000
-3.7%
949,456
+14.1%
0.00%0.0%
Q1 2019$3,097,000
-14.8%
832,420
-33.6%
0.00%
-50.0%
Q4 2018$3,633,000
+48.8%
1,252,766
+34.9%
0.00%
+100.0%
Q3 2018$2,441,000
+37.8%
928,338
+22.6%
0.00%0.0%
Q2 2018$1,771,000
-35.2%
756,901
-18.6%
0.00%0.0%
Q1 2018$2,733,000
+34.2%
929,659
+25.1%
0.00%0.0%
Q4 2017$2,037,000
-27.8%
743,316
-10.7%
0.00%0.0%
Q3 2017$2,823,000
+58.2%
832,796
+15.3%
0.00%0.0%
Q2 2017$1,784,000
+2.2%
722,113
-6.1%
0.00%0.0%
Q1 2017$1,746,000
+1718.8%
769,231
+1599.8%
0.00%
Q4 2016$96,000
-42.5%
45,254
-9.3%
0.00%
Q3 2016$167,000
+19.3%
49,910
+11.3%
0.00%
Q2 2016$140,000
-50.7%
44,829
-47.4%
0.00%
Q1 2016$284,000
+57.8%
85,216
+68.5%
0.00%
Q4 2015$180,000
-12.6%
50,577
+23.5%
0.00%
Q3 2015$206,000
-64.3%
40,956
-54.4%
0.00%
Q2 2015$577,000
+9.1%
89,896
+19.6%
0.00%
Q1 2015$529,000
-32.2%
75,150
-25.7%
0.00%
-100.0%
Q4 2014$780,000101,1180.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2014
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders